Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction
CARIOCA
2 other identifiers
interventional
750
2 countries
4
Brief Summary
Infarct size is a major determinant of prognosis after AMI. Evidence indicates that the combination of intracoronary ischemic conditioning (ICIC) and remote ischemic conditioning (RIC) can significantly reduce infarct size in STEMI patients. Whether the combination of these two interventions may improve clinical outcome after STEMI remains unknown. The objective of the present study is to determine whether combination of ICIC and RIC can improve STEMI patients clinical outcome at 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2017
CompletedFirst Posted
Study publicly available on registry
May 16, 2017
CompletedStudy Start
First participant enrolled
April 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2023
CompletedAugust 28, 2025
August 1, 2025
5.5 years
May 11, 2017
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Combined incidence of [all-cause mortality; worsening of heart failure during initial hospitalization or re-hospitalization for heart failure at 6 months after MI, large infarct defined as CK peak at 6 hours > 4500 UI/L]
6 months
Secondary Outcomes (9)
Cardiovascular death at 6 months.
6 months
Worsening of heart failure
6 months
Time to first event [all-cause mortality; worsening of heart failure during initial hospitalization or re-hospitalization for heart failure]
6 months
Major Adverse Cardiac Events (MACE)
6 months
Renal failure
6 months
- +4 more secondary outcomes
Study Arms (2)
RIC+ ICIC +
EXPERIMENTALPatients with remote ischemic conditioning and intracoronary ischemic conditioning
RCI - ICIC -
OTHERControl group with no remote ischemic conditioning and no intracoronary ischemic conditioning
Interventions
RIC: Four cycles of \[5 min brachial cuff inflation at 200 mmHg followed by 5 min of cuff deflation\] started as soon as possible prior to PCI reperfusion. At least one full cycle (inflation + deflation) has to be completed before PCI reperfusion. ICIC: Four cycles of \[1 min balloon inflation followed by 1 min balloon deflation\] started as soon as possible after reopening of the culprit coronary artery (maximum within 3 minutes after reflow). The balloon will be placed carefully above the culprit lesion so as to minimize potential micro-embolization.
Brachial cuff is positioned during 40 minutes but not inflated. No intracoronary balloon inflation.
Eligibility Criteria
You may qualify if:
- All (male and female) patients, aged over 18,
- Presenting within 12 hours of the onset of chest pain,
- For whom the clinical decision was made to treat with percutaneous coronary intervention (PCI),
- ST segment elevation ≥ 0.2 mV in two contiguous ECG leads,
- Written informed consent obtained or oral informed consent certified by a third party.
- Patients with cardiogenic shock,
- Patients with uncontrolled (treated or untreated) hypertension (\> 180/110 mmHg),
- Patients with loss of consciousness or confused,
- Patients without health coverage,
- Patient with any legal protection measure,
- Female patients currently pregnant (oral diagnosis) or women of childbearing age who were not using contraception.
You may not qualify if:
- Patients with main occlusion localized on :
- LAD: distal or ostial segment,
- Non dominant RCA / CX: mid or distal segment,
- Dominant RCA / CX: distal segment,
- Any other arteries apart LAD/CX/RCA; Patients with evidence of coronary collaterals to the risk region (Rentrop score ≥ 2); Patients with an opened (TIMI \> 1) culprit coronary artery on initial admission coronary angiography or a failed PCI (final TIMI=0).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Algemeen Ziekenhuis Sint Jan
Bruges, Belgium
CHU de Charleroi
Charleroi, Belgium
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Hopital Louis Pradel
Bron, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gilles Rioufol, Pr
Hôpital Louis Pradel 28 avenue Doyen Lépine, BP Lyon-Montchat, 69394LYON cedex 03
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2017
First Posted
May 16, 2017
Study Start
April 12, 2018
Primary Completion
October 3, 2023
Study Completion
October 3, 2023
Last Updated
August 28, 2025
Record last verified: 2025-08